
zzso zzso disease zzso is an important source of morbidity and mortality in patients with zzso zzso of zzso pathways may be a central mechanism for tumor spread and development of aggressive zzso This review will focus on novel risk factors and zzso for the development of zzso in patients with zzso as well as approaches for the treatment and prevention of zzso zzso 

Individual patient zzso zzso factors such as site and stage, and therapies including zzso zzso associated with higher risk of zzso are increasingly being zzso Novel risk zzso approaches focus on the use of zzso zzso including zzso and markers of zzso zzso such as zzso as well as zzso zzso zzso and treatment of zzso with zzso zzso zzso zzso or zzso in hospitalized medical and surgical cancer patients has been found to be well tolerated and zzso the appropriate role of zzso in ambulatory cancer patients, especially those with central zzso zzso remains to be zzso 

zzso zzso in all patients with cancer cannot be recommended because only a zzso of patients develop zzso and the use of zzso may be associated with unacceptably high risk of bleeding zzso Identification of patients at highest risk for zzso or bleeding who would benefit from careful prophylaxis is an important next zzso 

